Publication | Closed Access

Excellent safety and effectiveness of high-dose myrcludex-B monotherapy administered for 48 weeks in HDV-related compensated cirrhosis: A case report of 3 patients

HepatologyViral HepatitisLiver PhysiologyImmunologyHigh-dose Myrcludex-b MonotherapyHepatitisExcellent SafetyComplications Of CirrhosisAcute Liver FailureLiver DiseaseMedicineCirrhosisCase Report